Page last updated: 2024-11-13

ar 231453

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID24939268
CHEMBL ID461384
SCHEMBL ID114213
SCHEMBL ID2734562
MeSH IDM0511387

Synonyms (38)

Synonym
bdbm50244791
(2-fluoro-4-methanesulfonyl-phenyl)-{6-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-5-nitropyrimidin-4-yl}-amine
CHEMBL461384 ,
733750-99-7
AKOS016011527
ar 231453 ,
ar-231,453
n-(2-fluoro-4-methylsulfonylphenyl)-5-nitro-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amine
ar231453
gtpl5653
898528-64-8
HY-15564
CS-2475
SCHEMBL114213
07z1p4981i ,
(2-fluoro-4-(methanesulfonyl)phenyl)(6-(4-(3-isopropyl-(1,2,4)oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-yl)amine
unii-07z1p4981i
ar-231453
4-pyrimidinamine, n-(2-fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-(1-methylethyl)-1,2,4-oxadiazol-5-yl)-1-piperidinyl)-5-nitro-
SCHEMBL2734562
DTXSID80223614
[2-fluoro-4-(methanesulfonyl)phenyl][6-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-5-nitropyrimidin-4-yl]amine
n-(2-fluoro-4-methanesulfonylphenyl)-(6-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-5-nitro-pyrimidin-4-yl)amine
c21h24fn7o5s
n-(2-fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-amine
NCGC00386584-02
ar231453, >=98% (hplc)
Q4653529
ZB1517
BCP08600
EX-A2992
D82582
cid 24939268
n-(2-fluoro-4-methanesulfonylphenyl)-(6-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-5-nitropyrimidin-4-yl)amine
BA165448
AC-36279
n-(2-fluoranyl-4-methylsulfonyl-phenyl)-5-nitro-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amine
8WL ,

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Exposure of MIN6 and GLUTag cells to MW1219 enhanced glucose-stimulated insulin secretion and GLP-1 release; once-daily oral dosing of MW1219 for 6 weeks in diabetic db/db mice reduced hemoglobin A1c (HbA1c) and improved plasma glucose, insulin and GLP-1 levels; it also increased glucose tolerance."( High-throughput screening for GPR119 modulators identifies a novel compound with anti-diabetic efficacy in db/db mice.
Boutin, J; Feng, Y; He, M; Li, T; Nosjean, O; Renard, P; Wang, J; Wang, MW; Yang, D; Zhang, M; Zhao, J, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency1.89990.01237.983543.2770AID1645841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Amyloid-beta precursor proteinHomo sapiens (human)EC50 (µMol)0.00070.00074.20538.4100AID596023
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)EC50 (µMol)0.00070.00070.17911.4500AID596023
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)EC50 (µMol)0.00070.00070.42361.7650AID596023
Glucose-dependent insulinotropic receptorHomo sapiens (human)EC50 (µMol)0.62170.00071.61865.1300AID1141037; AID1333363; AID1610455; AID1688599; AID1732504; AID364147; AID596023
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glucose-dependent insulinotropic receptorRattus norvegicus (Norway rat)Activity0.01400.01400.01400.0140AID364150
Glucose-dependent insulinotropic receptorMus musculus (house mouse)Activity0.01200.01200.01200.0120AID364149
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (82)

Processvia Protein(s)Taxonomy
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
cognitionAmyloid-beta precursor proteinHomo sapiens (human)
G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglial cell activationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
suckling behaviorAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activation involved in immune responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of translationAmyloid-beta precursor proteinHomo sapiens (human)
protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
intracellular copper ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
endocytosisAmyloid-beta precursor proteinHomo sapiens (human)
response to oxidative stressAmyloid-beta precursor proteinHomo sapiens (human)
cell adhesionAmyloid-beta precursor proteinHomo sapiens (human)
regulation of epidermal growth factor-activated receptor activityAmyloid-beta precursor proteinHomo sapiens (human)
Notch signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
axonogenesisAmyloid-beta precursor proteinHomo sapiens (human)
learning or memoryAmyloid-beta precursor proteinHomo sapiens (human)
learningAmyloid-beta precursor proteinHomo sapiens (human)
mating behaviorAmyloid-beta precursor proteinHomo sapiens (human)
locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
axo-dendritic transportAmyloid-beta precursor proteinHomo sapiens (human)
cholesterol metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of cell population proliferationAmyloid-beta precursor proteinHomo sapiens (human)
adult locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
visual learningAmyloid-beta precursor proteinHomo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglia developmentAmyloid-beta precursor proteinHomo sapiens (human)
axon midline choice point recognitionAmyloid-beta precursor proteinHomo sapiens (human)
neuron remodelingAmyloid-beta precursor proteinHomo sapiens (human)
dendrite developmentAmyloid-beta precursor proteinHomo sapiens (human)
regulation of Wnt signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
extracellular matrix organizationAmyloid-beta precursor proteinHomo sapiens (human)
forebrain developmentAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection developmentAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of chemokine productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-1 beta productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-6 productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of tumor necrosis factor productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of multicellular organism growthAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of neuron differentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of glycolytic processAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of JNK cascadeAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAmyloid-beta precursor proteinHomo sapiens (human)
collateral sprouting in absence of injuryAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of inflammatory responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of synapse structure or activityAmyloid-beta precursor proteinHomo sapiens (human)
synapse organizationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of calcium-mediated signalingAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular process controlling balanceAmyloid-beta precursor proteinHomo sapiens (human)
synaptic assembly at neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
neuron apoptotic processAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulum calcium ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
neuron cellular homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeAmyloid-beta precursor proteinHomo sapiens (human)
response to interleukin-1Amyloid-beta precursor proteinHomo sapiens (human)
modulation of excitatory postsynaptic potentialAmyloid-beta precursor proteinHomo sapiens (human)
NMDA selective glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of spontaneous synaptic transmissionAmyloid-beta precursor proteinHomo sapiens (human)
cytosolic mRNA polyadenylationAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionAmyloid-beta precursor proteinHomo sapiens (human)
cellular response to amyloid-betaAmyloid-beta precursor proteinHomo sapiens (human)
regulation of presynapse assemblyAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection maintenanceAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of T cell migrationAmyloid-beta precursor proteinHomo sapiens (human)
central nervous system developmentAmyloid-beta precursor proteinHomo sapiens (human)
insulin secretionGlucose-dependent insulinotropic receptorHomo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayGlucose-dependent insulinotropic receptorHomo sapiens (human)
regulation of metabolic processGlucose-dependent insulinotropic receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
serine-type endopeptidase inhibitor activityAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
heparin bindingAmyloid-beta precursor proteinHomo sapiens (human)
enzyme bindingAmyloid-beta precursor proteinHomo sapiens (human)
identical protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
transition metal ion bindingAmyloid-beta precursor proteinHomo sapiens (human)
receptor ligand activityAmyloid-beta precursor proteinHomo sapiens (human)
PTB domain bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein serine/threonine kinase bindingAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor activator activityAmyloid-beta precursor proteinHomo sapiens (human)
protein bindingGlucose-dependent insulinotropic receptorHomo sapiens (human)
G protein-coupled receptor activityGlucose-dependent insulinotropic receptorHomo sapiens (human)
phosphatidylcholine bindingGlucose-dependent insulinotropic receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (41)

Processvia Protein(s)Taxonomy
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
dendriteAmyloid-beta precursor proteinHomo sapiens (human)
extracellular regionAmyloid-beta precursor proteinHomo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
nuclear envelope lumenAmyloid-beta precursor proteinHomo sapiens (human)
cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
mitochondrial inner membraneAmyloid-beta precursor proteinHomo sapiens (human)
endosomeAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulum lumenAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
Golgi lumenAmyloid-beta precursor proteinHomo sapiens (human)
Golgi-associated vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cytosolAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
clathrin-coated pitAmyloid-beta precursor proteinHomo sapiens (human)
cell-cell junctionAmyloid-beta precursor proteinHomo sapiens (human)
synaptic vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
membraneAmyloid-beta precursor proteinHomo sapiens (human)
COPII-coated ER to Golgi transport vesicleAmyloid-beta precursor proteinHomo sapiens (human)
axonAmyloid-beta precursor proteinHomo sapiens (human)
growth coneAmyloid-beta precursor proteinHomo sapiens (human)
platelet alpha granule lumenAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
endosome lumenAmyloid-beta precursor proteinHomo sapiens (human)
trans-Golgi network membraneAmyloid-beta precursor proteinHomo sapiens (human)
ciliary rootletAmyloid-beta precursor proteinHomo sapiens (human)
dendritic spineAmyloid-beta precursor proteinHomo sapiens (human)
dendritic shaftAmyloid-beta precursor proteinHomo sapiens (human)
perikaryonAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
apical part of cellAmyloid-beta precursor proteinHomo sapiens (human)
synapseAmyloid-beta precursor proteinHomo sapiens (human)
perinuclear region of cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
presynaptic active zoneAmyloid-beta precursor proteinHomo sapiens (human)
spindle midzoneAmyloid-beta precursor proteinHomo sapiens (human)
recycling endosomeAmyloid-beta precursor proteinHomo sapiens (human)
extracellular exosomeAmyloid-beta precursor proteinHomo sapiens (human)
receptor complexAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
receptor complexGlucose-dependent insulinotropic receptorHomo sapiens (human)
plasma membraneGlucose-dependent insulinotropic receptorHomo sapiens (human)
cytoplasmGlucose-dependent insulinotropic receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (41)

Assay IDTitleYearJournalArticle
AID1610455Agonist activity at recombinant human GPR119 expressed in HEK293 cells after 24 hrs by steady-glo luciferase assay2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists.
AID364162Tmax in Sprague-Dawley rat at 10 mg/kg, po2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID1333365Induction of insulin secretion in ICR mouse primary pancreatic islets in presence of 16.8 mM glucose after 1 hr relative to control2016European journal of medicinal chemistry, Nov-29, Volume: 124Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents.
AID364164AUC in Sprague-Dawley rat at 10 mg/kg, po2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364154Cmax in C57BL/6J mouse at 10 mg/kg, po2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364152Inhibition of hERG upto 10 uM by patch clamp assay2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364149Agonist activity at mouse GPR119 transfected in Xenopus dermal melanophore assessed as dispersion of melatonin-induced pigmentation2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364161Effect on glucose excursion in Sprague-Dawley rat at 30 mg/kg, po by oral glucose tolerance test2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID1688598Agonist activity at CREB-LBD and Gal4-DBD fused recombinant human GPR119 expressed in HEK293 cells at 1 uM by firefly luciferase assay relative to AR231453
AID1732504Agonist activity at human GPR119 stably transfected in CHO-K1 cells assessed as increase in cAMP stimulation after 1 hr by enzyme immunoassay2021Bioorganic & medicinal chemistry, 04-01, Volume: 35Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.
AID364168Inhibition of cytochrome2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID1141038Agonist activity at human GPR119 overexpressed in CHO cells assessed as stimulation of cAMP production by HTRF assay relative to AR2314532014Bioorganic & medicinal chemistry letters, May-15, Volume: 24, Issue:10
Discovery of structurally novel, potent and orally efficacious GPR119 agonists.
AID364153Tmax in C57BL/6J mouse at 10 mg/kg, po2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364147Agonist activity at CPR119 transfected in Xenopus dermal melanophore assessed as dispersion of melatonin-induced pigmentation2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364157Agonist activity at GPR119 in hamster HIT-T15 cells stimulation of assessed as cAMP production2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364158Increase in glucose dependent insulin release in wild type C57BL/6J mouse at 20 mg/kg, po by oral glucose tolerance test2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID1333363Agonist activity at CREB-LBD and GAL4-DBD fused human GPR119 expressed in HEK293 cells by luciferase reporter gene assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents.
AID364166Oral bioavailability in Sprague-Dawley rat at 10 mg/kg2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364163Cmax in Sprague-Dawley rat at 10 mg/kg, po2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID1333366Induction of insulin secretion in ICR mouse primary pancreatic islets in presence of 2.8 mM glucose after 1 hr relative to control2016European journal of medicinal chemistry, Nov-29, Volume: 124Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents.
AID364165Half life in Sprague-Dawley rat at 10 mg/kg, po2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364159Increase in glucose dependent insulin release in GPR119 deficient C57BL/6J mouse at 20 mg/kg, po by oral glucose tolerance test2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID1141037Agonist activity at human GPR119 overexpressed in CHO cells assessed as stimulation of cAMP production by HTRF assay2014Bioorganic & medicinal chemistry letters, May-15, Volume: 24, Issue:10
Discovery of structurally novel, potent and orally efficacious GPR119 agonists.
AID364160Increase in glucose dependent insulin release in diabetic KK/ay mouse by oral glucose tolerance test2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364167Activity at DPP42008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364148Agonist activity at cynomolgus monkey GPR119 transfected in Xenopus dermal melanophore assessed as dispersion of melatonin-induced pigmentation2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364156Half life in C57BL/6J mouse at 10 mg/kg, po2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID645385Intrinsic activity at human GPR119 receptor assessed as cAMP production by HTRF assay relative to AR2314532012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile.
AID364155AUC in C57BL/6J mouse at 10 mg/kg, po2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID596023Agonist activity at human GPR119 by melanophore assay2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control.
AID364151Agonist activity at dog GPR119 transfected in Xenopus dermal melanophore assessed as dispersion of melatonin-induced pigmentation2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID364150Agonist activity at rat GPR119 transfected in Xenopus dermal melanophore assessed as dispersion of melatonin-induced pigmentation2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
AID1732505Agonist activity at human GPR119 stably transfected in CHO-K1 cells assessed as increase in cAMP stimulation after 1 hr by enzyme immunoassay relative to AR2314532021Bioorganic & medicinal chemistry, 04-01, Volume: 35Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.
AID1237202In vivo activation of GPR119 in normoglycemic 129SVE mouse assessed as increase in GIP level in plasma at 30 mg/kg, po measured after 45 mins relative to vehicle-treated control2015Bioorganic & medicinal chemistry letters, Aug-01, Volume: 25, Issue:15
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist series.
AID1688599Agonist activity at CREB-LBD and Gal4-DBD fused recombinant human GPR119 expressed in HEK293 cells by firefly luciferase assay
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1345261Human GPR119 (GPR18, GPR55 and GPR119)2007Endocrinology, Jun, Volume: 148, Issue:6
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (13.04)29.6817
2010's16 (69.57)24.3611
2020's4 (17.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.16 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]